Undetected Jawbone Marrow Defects as Inflammatory and Degenerative Signaling Pathways: Chemokine RANTES/CCL5 as a Possible Link Between the Jawbone and Systemic Interactions?

References

• Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett. 2007;256(2):137–165. doi:10.1016/j.canlet.2007.05.013
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Historical review of cytokines. Eur J Immunol. 2007;37(Suppl 1):S34–S45. doi:10.1002/eji.200737772
   PubMedGoogle Scholar
• Kaplanski G, Farnarier C, Kaplanski S, et al. Interleukin-1 induces interleukin-8 from endothelial cells by a juxtacrine mechanism. Blood. 1994;84(12):4242–4248. doi:10.1182/blood.V84.12.4242.bloodjournal84124242
   PubMed Web of Science ®Google Scholar
• Apte RN, Douvdevani A, Zoller M, et al. Cytokine-induced tumorigenicity: endogenous interleukin-1α expressed by fibrosarcoma cells confers reduced tumorigenicity. Immunol Lett. 1993;39(1):45–52. doi:10.1016/0165-2478(93)90163-V
   PubMed Web of Science ®Google Scholar
• Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23(5):479–490. doi:10.1016/j.immuni.2005.09.015
   PubMed Web of Science ®Google Scholar
• Lechner J, von Baehr V. RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease? Int J Gen Med. 2013;6:277–290. doi:10.2147/IJGM.S43852
   PubMedGoogle Scholar
• Lechner J, Schulz T, von Baehr V. Immunohistological staining of unknown chemokine RANTES/CCL5 expression in jawbone marrow defects—osteoimmunology and disruption of bone remodeling in clinical case studies targeting on predictive preventive personalized medicine. EPMA J. 2019;10(4):1–14. doi:10.1007/s13167-019-00182-1
   PubMed Web of Science ®Google Scholar
• Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry. 1996;35(11):3362–3367. doi:10.1021/bi952950g
   PubMed Web of Science ®Google Scholar
• Sicoli D, Jiao X, Ju X, et al. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines. Cancer Res. 2014;74(23):7103–7114. doi:10.1158/0008-5472.CAN-14-0612
   PubMed Web of Science ®Google Scholar
• Velasco-Velázquez M, Xolalpa W, Pestell RG. CCL5/CCR5 in breast cancer. Expert Opin Ther Targets. 2014;18(11):1265–1275. doi:10.1517/14728222.2014.949238
   PubMed Web of Science ®Google Scholar
• Segall RO, Del Rio CE. Cavitational bone defect: a diagnostic challenge. J Endourol. 1991;17(8):396. doi:10.1016/S0099-2399(06)81993-X
   Google Scholar
• Lechner J. Validation of dental X-ray by cytokine RANTES– comparison of X-ray findings with cytokine overexpression in jawbone. Clin Cosmet Investig Dent. 2014;6:71–79. doi:10.2147/CCIDE.S69807
   PubMedGoogle Scholar
• Norton MR, Gamble C. Bone classification: an objective scale of bone density using the computerized tomography scan. Clin Oral Implants Res. 2001;12(1):79–84. doi:10.1034/j.1600-0501.2001.012001079.x
   PubMed Web of Science ®Google Scholar
• Misch CE. Bone density: a key determinant for clinical success. In: Misch CE, editor. Contemporary Implant Dentistry. 2nd ed. St Louis: CV Mosby Company; 1999:109–118.
   Google Scholar
• Mah P, Reeves TE, McDavid WD. Deriving Hounsfield units using grey levels in cone-beam computed tomography. Dentomaxillofac Radiol. 2010;39(6):323–335. doi:10.1259/dmfr/19603304
   PubMed Web of Science ®Google Scholar
• Lee S, Gantes B, Riggs M, Crigger M. Bone density assessments of dental implant sites: 3. Bone quality evaluation during osteotomy and implant placement. Int J Oral Maxillofac Implants. 2007;22(2):208–212.
   PubMed Web of Science ®Google Scholar
• Lechner J, von Baehr V. Chemokine RANTES/CCL5 as an unknown link between wound healing in the jawbone and systemic disease: is prediction and tailored treatments in the horizon? EPMA J. 2015;6(1):10. doi:10.1186/s13167-015-0032-4
   PubMed Web of Science ®Google Scholar
• Lechner J, Rudi T, von Baehr V. Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis. Clin Cosmet Investig Dent. 2018;10:251–262. doi:10.2147/CCIDE.S184498
   PubMed Web of Science ®Google Scholar
• Lechner J, von Baehr V. Hyperactivated signaling pathways of chemokine RANTES/CCL5 in osteopathies of jawbone in breast cancer patients—case report and research. Breast Cancer (Auckl). 2014;8:89–96. doi:10.4137/BCBCR.S15119
   PubMedGoogle Scholar
• Lechner J, Huesker K, von Baehr V. Impact of RANTES from jawbone on chronic fatigue syndrome. J Biol Regul Homeost Agents. 2017;31(2):321–327.
   PubMed Web of Science ®Google Scholar
• Puxeddu I, Panza F, Pratesi F, et al. CCL5/RANTES, sVCAM-1, and sICAM-1 in chronic spontaneous urticaria. Int Arch Allergy Immunol. 2013;162(4):330–334. doi:10.1159/000354922
   PubMed Web of Science ®Google Scholar
• Bruno PP, Carpino F, Carpino G, Zicari A. An overview on immune system and migraine. Eur Rev Med Pharmacol Sci. 2007;11(4):245–248.
   PubMed Web of Science ®Google Scholar
• Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y. Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol. 2016;73(11):1316–1324. doi:10.1001/jamaneurol.2016.2742
   PubMed Web of Science ®Google Scholar
• Aldinucci D, Colombatti A. The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm. 2014;2014:292376. doi:10.1155/2014/292376
   PubMed Web of Science ®Google Scholar
• Huang Y, Zheng S, Wang R, Tang C, Zhu J, Li J. CCL5 and related genes might be the potential diagnostic biomarkers for the therapeutic strategies of rheumatoid arthritis. Clin Rheumatol. 2019;38(9):2629–2635. doi:10.1007/s10067-019-04533-1
   PubMed Web of Science ®Google Scholar
• Zhou Y, Guo W, Zhu Z, et al. Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury. J Neuroinflammation. 2018;15(1):253. doi:10.1186/s12974-018-1297-z
   PubMedGoogle Scholar
• Rudemiller NP, Crowley SD. The role of chemokines in hypertension and consequent target organ damage. Pharmacol Res. 2017;119:404–411. doi:10.1016/j.phrs.2017.02.026
   PubMed Web of Science ®Google Scholar
• von Luettichau I, Nelson PJ, Pattison JM, et al. RANTES chemokine expression in diseased and normal human tissues. Cytokine. 1996;8(1):89–98. doi:10.1006/cyto.1996.0012
   PubMed Web of Science ®Google Scholar
• Tsukishiro S, Suzumori N, Nishikawa H, Arakawa A, Suzumori K. Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder. Gynecol Oncol. 2006;102(3):542–545. doi:10.1016/j.ygyno.2006.01.029
   PubMed Web of Science ®Google Scholar